NCT07062887Recruiting
Digital Mindfulness for Young Adults With Type 1 Diabetes
A Digital Mindfulness and Biometric Feedback Application for Young Adults With Type 1 Diabetes
Source: ClinicalTrials.gov · Last updated 9 Feb 2026
Brief summary (registry, in English)
The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute insulin deficiency diabetes. Mindfulness is the practice of being aware of your thoughts and feelings in the moment without judgment or negative reaction. All participants will receive mindfulness guidance and personalized feedback about the relationship among your mindfulness, blood sugar, stress, and sleep.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 3 Jul 2025
- Start date
- 4 Feb 2026
- Primary completion date
- Sept 2026
- Lead sponsor
- Yale University
- Diseases
- Type 1 diabetes
- NCT number
- NCT07062887
What you commit to
- Study type: Interventional
- Planned participants: 10
- From 4 Feb 2026 to the primary completion date, Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Current severe untreated psychiatric illness (e.g., bipolar disorder, schizophrenia, major depression, panic disorder, borderline personality disorder, organic mood or mental disorders) or active suicidal ideation
Other
- Current meditation or mindfulness practice meeting or exceeding the study's recommended schedule
- New or unstable psychopharmaceutical treatment in past 2 months.
- Current or planned pregnancy during study period.
Who the study is looking for
- Receiving diabetes care at Yale New Haven Children's Hospital or Yale New Haven Hospital.
- Sign and date informed consent form we will provide
- Willingness to complete procedures and availability for duration of the study
- Aged 18-30 years
- Diagnosed with type 1 diabetes (T1D) or other absolute insulin deficiency diabetes (latent autoimmune diabetes of adulthood, diabetes secondary to pancreatitis) for at least 1 year.
- User of a continuous glucose monitor (CGM) in your routine clinical care for at least the past 2 weeks.
- Able to use a smartphone.
- Able to read and write English.
Age in the registry: 18 years to 30 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yale University School Of Medicine Coordinator of this site? Confirm its status | New Haven | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.